Clik here to view.
ボディ・ビジョン・メディカル、株式会社アムコとの専属販売契約を締結
カリフォルニア州キャンベル （ビジネスワイヤ） — AI駆動の術中イメージング医療機器のリーディング・カンパニーであるボディ・ビジョン・メディカルは、自社の最新技術LungVision®のリアルタイム術中CTイメージング・システムへのアクセスを日本へ拡大すべく、株式会社アムコとの専属販売契約を締結したことを発表しました。...
View ArticleClik here to view.
GSK Enters Into a Multi-Year Data Licence Agreement With Ochre Bio to Further...
OXFORD, England Ochre Bio, a pioneer in chronic liver disease medicine development, has today announced the start of a multi-year data licence agreement with GSK. The partnership will provide GSK...
View ArticleClik here to view.
Takeda Presents Long-Term Data from Phase 3 ADVANCE-CIDP 3 Clinical Trial of...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda (TSE:4502/NYSE:TAK) today announced data from the Phase 3 ADVANCE-CIDP 3 clinical trial, a long-term extension study evaluating the safety and efficacy of...
View ArticleClik here to view.
Takeda在PNS年会上展示慢性炎症性脱髓鞘性多发性神经病(CIDP)患者使用HYQVIA®的3期ADVANCE-CIDP 3临床试验的长期数据
日本大阪和马萨诸塞州剑桥 (美国商业资讯)– Takeda (TSE:4502/NYSE:TAK) 今天公布了3期ADVANCE-CIDP 3临床试验的数据，这是一项长期扩展研究，旨在评估HYQVIA®...
View ArticleClik here to view.
武田薬品、PNS年次総会にて慢性炎症性脱髄性多発神経炎（CIDP）患者を対象としたHYQVIA®の第3相ADVANCE-CIDP3臨床試験の長期データを発表
大阪、日本&ケンブリッジ、マサチューセッツ州 （ビジネスワイヤ） — 武田薬品工業株式会社 （TSE：4502/NYSE：TAK）...
View ArticleClik here to view.
QPS宣布新调整的全球临床研究运营领导团队
纽瓦克，德克萨斯州 (美国商业资讯)– 全球领先的合同研究组织 (CRO) QPS欣然宣布了新调整的临床研究运营领导团队。新临床领导团队将进一步调整现有的全球医疗事务、监管事务、数据服务和临床运营部门，使之与QPS现已取得成功地I期临床业务保持一致。增强的全球领导能力将帮助QPS满足快速发展的全球药物开发领域对敏捷性、灵活性和速度的需求。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Clik here to view.
Takeda Announces Approval of LIVTENCITY® (maribavir) in Japan for...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda (TSE:4502/NYSE:TAK) today announced that LIVTENCITY® (maribavir) has been approved by the Japanese Ministry of Health, Labour and Welfare (MHLW) for...
View ArticleClik here to view.
Imricor’s VISABL-AFL Trial for US FDA Approval Commences at Cardiovascular...
MINNEAPOLIS Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in real-time iCMR cardiac ablation products, is pleased to announce that the Vision-MR Ablation Catheter...
View ArticleClik here to view.
Dr. Reddy’s to Acquire Nicotinell and Related Portfolio in Significant Step...
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”), a global pharmaceutical...
View ArticleClik here to view.
Reflow Medical Enrolls First Patients in Pilot Study of Coronary...
SAN CLEMENTE, Calif. Reflow Medical, Inc., a developer of innovative devices focused on cardiovascular disease, announces the first patient enrollments in “A pilot study of the Drug-Eluting Coronary...
View ArticleClik here to view.
Dongguk University Ilsan Hospital Completes First Brain Tumor Treatments with...
GOYANG-SI, South Korea ZAP Surgical Systems, Inc., a global leader in surgical robotics, proudly announces the completion of first patient treatments at Dongguk University Ilsan Hospital using the...
View ArticleClik here to view.
Carestream推出CARESTREAM DRX-Evolution Plus系统和ImageView软件的新增强功能以改善技术人员使用体验和患者检查流程
纽约州罗切斯特 (美国商业资讯)– Carestream Health今天宣布为其ImageView软件和DRX-Evolution Plus系统增加新的增强功能，标志着其业界领先的创新成像解决方案系列产品实现最新改进。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20240703392599/zh-CN/...
View ArticleClik here to view.
医療技師体験と患者のワークフロー向上に向け、ケアストリームがCARESTREAM DRX-Evolution...
ニューヨーク州、ロチェスター （ビジネスワイヤ） — ケアストリームヘルスは、革新的で業界をリードするイメージング・ソリューションの最新の改良として、ImageViewソフトウエアおよびDRX-Evolution Plusシステムに新しい機能強化を追加したことを発表しました。...
View ArticleClik here to view.
Zelis® Earns 2024 Great Place to Work® Certification in India
HYDERABAD, India Zelis, a leading provider of healthcare technology solutions, achieves Great Place to Work certification in India for the first time. The honor was determined based on local...
View ArticleClik here to view.
S.BIOMEDICS Dopamine Cell Therapy for Parkinson’s Disease with TED-A9 Shows...
SEOUL, South Korea S.BIOMEDICS (KOSDAQ: 304360) announced positive one-year assessment data from the first 3 participants (first low dose cohort) of Phase I/IIa clinical trial for Parkinson’s...
View ArticleClik here to view.
MMI签订多个分销协议并获得监管机构批准为全球扩张注入动力
佛罗里达州杰克逊维尔 (美国商业资讯)– MMI（Medical Microinstruments, Inc.）是一家机器人技术公司，致力于为病情复杂的患者提供更多治疗选择并改善临床疗效。今天该公司宣布了跨越两大洲的里程碑进展，进一步扩大了Symani®手术系统的全球覆盖范围。该公司宣布： 与日本领先的医疗设备开发商和制造商Gunze Medical...
View ArticleClik here to view.
MMI Builds Global Momentum with Multiple Distribution Agreements and...
JACKSONVILLE, Fla. MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today...
View ArticleClik here to view.
MMI、複数の販売契約と規制承認でグローバル展開に弾みをつける
フロリダ州、ジャクソンビル （ビジネスワイヤ） — 複雑な病状を抱える患者の治療選択肢を増やし、臨床転帰の改善に取り組むロボティクス企業のMMI（Medical Microinstruments, Inc.）は、Symani® Surgical Systemのグローバル展開拡大に向けた二大陸にわたるマイルストーンを発表しました。発表内容は以下の通りです。...
View ArticleClik here to view.
Guided Therapeutics’ Announces Data from Chinese NMPA Clinical Study Signed...
PEACHTREE CORNERS, Ga. Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that leading physicians from four prestigious medical centers have...
View Article